Narrative review / 2013
Diabetes is associated with an increased risk of total cancer and several site-specific cancers, but a decreased risk of prostate cancer.
This review evaluates evidence linking diabetes mellitus to cancer risk. Meta-analyses indicate that diabetes increases the risks of total cancer as well as cancers of the breast, endometrium, bladder, liver, colorectum, and pancreas, while decreasing the risk of prostate cancer. Proposed mechanisms include insulin resistance, secondary hyperinsulinemia, and hyperglycemia, alongside lifestyle factors such as obesity, smoking, and lack of exercise. Additionally, diabetes treatments like metformin may exert potential anticancer effects.
Shows an association, not proof of cause and effect.
- Study type
- Narrative review
- Who was studied
- Individuals with diabetes mellitus
- What was measured
- Risk of total and site-specific cancers
THE PAPER
Latest insights into the risk of cancer in diabetes.
Noto H, Goto A, Tsujimoto T, Osame K, Noda M. J Diabetes Investig, 2013.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.